Showing 1 - 3 results of 3 for search 'Ying Cheng, MD', query time: 0.02s
Refine Results
-
1
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis by Jie Wang, MD, PhD, Yi-Long Wu, MD, Shun Lu, MD, PhD, Qun Wang, MD, Shanqing Li, MD, Wen-Zhao Zhong, MD, PhD, Qiming Wang, MD, Wei Li, MD, PhD, Buhai Wang, MD, Jun Chen, MD, Ying Cheng, MD, Hongbing Duan, MD, Gaofeng Li, MD, Li Shan, MD, Yangbo Liu, MS, Jing Liu, MD, Xiangning Huang, PhD, Ana Bolanos, MD, Jie He, MD, PhD
Published 2024-02-01
Article -
2
Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations by Shun Lu, MD, Jian Fang, MD, Xingya Li, MD, Lejie Cao, MD, Jianying Zhou, MD, Qisen Guo, MD, Zongan Liang, MD, Ying Cheng, MD, Liyan Jiang, MD, Nong Yang, MD, Zhigang Han, MD, Jianhua Shi, MD, Yuan Chen, MD, Hua Xu, MD, Helong Zhang, MD, Gongyan Chen, MD, Rui Ma, MD, Sanyuan Sun, MD, Yun Fan, MD, Songhua Fan, MD, Jie Yu, MD, Puhan Lu, PhD, Xian Luo, MS, Weiguo Su, PhD
Published 2022-10-01
Article -
3
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol by Jinjie He MD, Yue Liu PhD, Chengcheng Liu PhD, Hanguang Hu PhD, Lifeng Sun MD, Dong Xu MD, Jun Li MD, Junye Wang MD, Xiaobing Chen MD, Rongbo Lin MD, Yi Jiang MD, Yanqiao Zhang MD, Weisheng Zhang MD, Ying Cheng MD, Xiaohong Wu MD, Mingzhi Fang MD, Enxiao Li MD, Ye Xu MD, Ye Chen MD, Jiayi Li MD, Yanyan Cui MD, Zhanyu Pan MD, Songnan Zhang MD, Ying Yuan PhD, Kefeng Ding PhD
Published 2023-02-01
Article